These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 16608039)

  • 61. Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.
    Capussotti L; Muratore A; Massucco P; Ferrero A; Polastri R; Bouzari H
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S64-8. PubMed ID: 14762842
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
    Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G
    Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma.
    Pawlik TM; Poon RT; Abdalla EK; Zorzi D; Ikai I; Curley SA; Nagorney DM; Belghiti J; Ng IO; Yamaoka Y; Lauwers GY; Vauthey JN;
    Arch Surg; 2005 May; 140(5):450-7; discussion 457-8. PubMed ID: 15897440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
    Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prognostic value of CLIP score system for patients with resection of hepatocellular carcinoma].
    Zhao W; Ma Z; Zhou X; Feng Y; Fang B
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):321-5. PubMed ID: 12133332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combined hepatic artery chemoembolization and portal vein chemotherapy after radical resection of hepatocellular carcinoma to prevent recurrence].
    Li H; Ou Q; Chen J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):61-3. PubMed ID: 11776603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surgical indications for advanced hepatocellular carcinoma.
    Shimada M; Yamashita Y; Hamatsu T; Rikimaru T; Hasegawa H; Gion T; Shirabe K; Takenaka K; Sugimachi K
    Hepatogastroenterology; 2000; 47(34):1095-9. PubMed ID: 11020886
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.
    Liu J; Wang Y; Zhang D; Liu B; Ou Q
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):186-94. PubMed ID: 22081008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term prognosis after arterio-portal embolization for hepatocellular carcinoma.
    Mamada Y; Tajiri T; Akimaru K; Yoshida H; Taniai N
    Hepatogastroenterology; 2004; 51(55):234-6. PubMed ID: 15011871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma.
    Sakon M; Monden M; Umeshita K; Gotoh M; Kanai T; Mori T; Okamura J
    Int Surg; 1994; 79(1):38-42. PubMed ID: 8063553
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma.
    Kondo K; Chijiiwa K; Makino I; Kai M; Maehara N; Ohuchida J; Naganuma S
    J Hepatobiliary Pancreat Surg; 2005; 12(5):399-404. PubMed ID: 16258809
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
    Morimoto Y; Tanaka Y; Ito T; Nakahara M; Nakaba H; Nishida T; Fujikawa M; Ito T; Yamamoto S; Kitagawa T
    J Hepatobiliary Pancreat Surg; 2003; 10(6):432-40. PubMed ID: 14714164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
    Park JH; Koh KC; Choi MS; Lee JH; Yoo BC; Paik SW; Rhee JC; Joh JW
    Am J Surg; 2006 Jul; 192(1):29-33. PubMed ID: 16769271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein.
    Tanaka A; Morimoto T; Yamaoka Y
    Hepatogastroenterology; 1996; 43(9):637-43. PubMed ID: 8799408
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.